Interpace Biosciences Statistics
Total Valuation
IDXG has a market cap or net worth of 3.45 million. The enterprise value is 6.49 million.
Market Cap | 3.45M |
Enterprise Value | 6.49M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
Earnings Date | Aug 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
IDXG has 4.42 million shares outstanding. The number of shares has increased by 391.99% in one year.
Current Share Class | 4.42M |
Shares Outstanding | 4.42M |
Shares Change (YoY) | +391.99% |
Shares Change (QoQ) | -44.28% |
Owned by Insiders (%) | 21.85% |
Owned by Institutions (%) | 3.25% |
Float | 3.46M |
Valuation Ratios
The trailing PE ratio is 2.31.
PE Ratio | 2.31 |
Forward PE | n/a |
PS Ratio | 0.07 |
PB Ratio | -5.93 |
P/TBV Ratio | n/a |
P/FCF Ratio | 0.68 |
P/OCF Ratio | 0.58 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 0.66, with an EV/FCF ratio of 1.28.
EV / Earnings | 0.90 |
EV / Sales | 0.13 |
EV / EBITDA | 0.66 |
EV / EBIT | 0.74 |
EV / FCF | 1.28 |
Financial Position
The company has a current ratio of 1.34
Current Ratio | 1.34 |
Quick Ratio | 1.15 |
Debt / Equity | n/a |
Debt / EBITDA | 0.43 |
Debt / FCF | 0.83 |
Interest Coverage | 16.93 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | 41.41% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 151.70% |
Revenue Per Employee | 434,802 |
Profits Per Employee | 64,658 |
Employee Count | 111 |
Asset Turnover | 3.62 |
Inventory Turnover | 14.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.30% in the last 52 weeks. The beta is 0.69, so IDXG's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -47.30% |
50-Day Moving Average | 0.95 |
200-Day Moving Average | 1.70 |
Relative Strength Index (RSI) | 44.06 |
Average Volume (20 Days) | 7,842 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, IDXG had revenue of 48.26 million and earned 7.18 million in profits. Earnings per share was 0.33.
Revenue | 48.26M |
Gross Profit | 30.98M |
Operating Income | 8.82M |
Pretax Income | 7.91M |
Net Income | 7.18M |
EBITDA | 9.17M |
EBIT | 8.82M |
Earnings Per Share (EPS) | 0.33 |
Balance Sheet
The company has 1.20 million in cash and 4.24 million in debt, giving a net cash position of -3.04 million or -0.69 per share.
Cash & Cash Equivalents | 1.20M |
Total Debt | 4.24M |
Net Cash | -3.04M |
Net Cash Per Share | -0.69 |
Equity (Book Value) | -582,000 |
Book Value Per Share | -0.13 |
Working Capital | 2.98M |
Cash Flow
In the last 12 months, operating cash flow was 5.94 million and capital expenditures -848,000, giving a free cash flow of 5.09 million.
Operating Cash Flow | 5.94M |
Capital Expenditures | -848,000 |
Free Cash Flow | 5.09M |
FCF Per Share | 1.15 |
Margins
Gross margin is 64.20%, with operating and profit margins of 18.28% and 15.83%.
Gross Margin | 64.20% |
Operating Margin | 18.28% |
Pretax Margin | 16.38% |
Profit Margin | 15.83% |
EBITDA Margin | 18.99% |
EBIT Margin | 18.28% |
FCF Margin | 10.55% |
Dividends & Yields
IDXG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -391.99% |
Shareholder Yield | n/a |
Earnings Yield | 208.03% |
FCF Yield | 147.56% |
Stock Splits
The last stock split was on January 15, 2020. It was a reverse split with a ratio of 0.1.
Last Split Date | Jan 15, 2020 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
IDXG has an Altman Z-Score of -16.69. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -16.69 |
Piotroski F-Score | n/a |